Analyst Consensus ?
ConsensusHold29 ratings
Bullish310.3%
Neutral2069.0%
Bearish620.7%
FN2 Earnings Intelligence
The Clorox Company analyst ratings
The Clorox Company (CLX) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$88Current
$80Low
$121.04Average
$185High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 31, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| JP Morgan | Underweight | Underweight | Maintain | Oct 19, 2026 |
| Barclays | Underweight | Underweight | Maintain | Oct 16, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Oct 15, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Oct 14, 2026 |
| TD Cowen | Hold | Hold | Maintain | Oct 13, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Oct 5, 2026 |
| UBS | Neutral | Neutral | Maintain | Aug 4, 2026 |
| Evercore ISI Group | Underperform | Underperform | Maintain | Aug 4, 2026 |
| Jefferies | Hold | Buy | Downgrade | Jul 28, 2026 |
| BNP Paribas | Neutral | Neutral | Maintain | Jul 20, 2026 |
| Deutsche Bank | Hold | Hold | Maintain | Mar 30, 2026 |
| Goldman Sachs | Sell | Sell | Maintain | Jan 7, 2026 |
| B of A Securities | Neutral | Neutral | Maintain | Oct 8, 2025 |
| DA Davidson | Neutral | Neutral | Maintain | Feb 5, 2025 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Jan 30, 2025 |
| Bernstein | Market Perform | Underperform | Upgrade | Oct 12, 2023 |
| Raymond James | Market Perform | Outperform | Downgrade | Oct 5, 2023 |
| Atlantic Equities | Neutral | Underweight | Upgrade | Aug 3, 2023 |
| Credit Suisse | Underperform | Underperform | Maintain | Nov 2, 2022 |
| Argus Research | Hold | Buy | Downgrade | Sep 3, 2021 |
| CFRA | Hold | Sell | Upgrade | Mar 4, 2020 |
| Bank of America | Neutral | Neutral | Maintain | Oct 3, 2019 |
| BMO Capital | Outperform | Outperform | Maintain | Nov 2, 2018 |
| Argus | Buy | Hold | Upgrade | Sep 25, 2018 |
| B. Riley FBR | Sell | Neutral | Downgrade | May 5, 2018 |
| Sterne Agee CRT | Neutral | Buy | Downgrade | Feb 26, 2016 |
| Sterne Agee | Neutral | Buy | Downgrade | Feb 26, 2016 |
| B. Riley Securities | Neutral | Neutral | Maintain | Feb 9, 2016 |
| Wellington Shields | Buy | Hold | Upgrade | Mar 18, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $88. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Deutsche Bank | Steve Powers | $95 | $84.8 | +8.0% | Oct 19, 2026 |
| Barclays | Analyst unavailable | $80 | $86.2 | -9.1% | Oct 16, 2026 |
| UBS | Analyst unavailable | $91 | $87 | +3.4% | Oct 15, 2026 |
| Morgan Stanley | Analyst unavailable | $87 | $87.34 | -1.1% | Oct 15, 2026 |
| Deutsche Bank | Analyst unavailable | $98 | $101.27 | +11.4% | Aug 4, 2026 |
| UBS | Analyst unavailable | $105 | $100.55 | +19.3% | Aug 4, 2026 |
| Evercore ISI | Analyst unavailable | $99 | $100.72 | +12.5% | Aug 4, 2026 |
| Barclays | Lauren Lieberman | $84 | $98.26 | -4.5% | Aug 4, 2026 |
| Jefferies | Kaumil Gajrawala | $98 | $97.41 | +11.4% | Jul 28, 2026 |
| Evercore ISI | Javier Escalante | $98 | $93.62 | +11.4% | Jul 23, 2026 |
| Deutsche Bank | Analyst unavailable | $94 | $96.25 | +6.8% | Jul 22, 2026 |
| Morgan Stanley | Analyst unavailable | $97 | $88.25 | +10.2% | May 1, 2026 |
| Goldman Sachs | Bonnie Herzog | $83 | $87.73 | -5.7% | May 1, 2026 |
| Evercore ISI | Javier Escalante | $110 | $88.3 | +25.0% | May 1, 2026 |
| Deutsche Bank | Steve Powers | $91 | $96.44 | +3.4% | May 1, 2026 |
| UBS | Analyst unavailable | $96 | $96.44 | +9.1% | May 1, 2026 |
| Barclays | Analyst unavailable | $85 | $96.44 | -3.4% | May 1, 2026 |
| Jefferies | Kaumil Gajrawala | $139 | $100.34 | +58.0% | Apr 21, 2026 |
| RBC Capital | Analyst unavailable | $127 | $107.62 | +44.3% | Apr 9, 2026 |
| Wells Fargo | Analyst unavailable | $110 | $105.67 | +25.0% | Apr 8, 2026 |
| Wells Fargo | Chris Carey | $125 | $125.94 | +42.0% | Feb 17, 2026 |
| Redburn Partners | Analyst unavailable | $117 | $124.64 | +33.0% | Feb 13, 2026 |
| UBS | Peter Grom | $121 | $117.35 | +37.5% | Feb 4, 2026 |
| RBC Capital | Analyst unavailable | $132 | $116.62 | +50.0% | Feb 4, 2026 |
| Deutsche Bank | Analyst unavailable | $114 | $115.22 | +29.5% | Jan 23, 2026 |
| Wells Fargo | Analyst unavailable | $115 | $112.2 | +30.7% | Jan 23, 2026 |
| Barclays | Analyst unavailable | $109 | $109.26 | +23.9% | Jan 16, 2026 |
| UBS | Peter Grom | $115 | $110.64 | +30.7% | Jan 14, 2026 |
| Goldman Sachs | Analyst unavailable | $94 | $100.61 | +6.8% | Jan 7, 2026 |
| Wells Fargo | Analyst unavailable | $108 | $99.67 | +22.7% | Jan 5, 2026 |
| Morgan Stanley | Dara Mohsenian | $125 | $109.42 | +42.0% | Nov 4, 2025 |
| UBS | Peter Grom | $119 | $109.14 | +35.2% | Nov 4, 2025 |
| Wells Fargo | Analyst unavailable | $117 | $109.14 | +33.0% | Nov 4, 2025 |
| Jefferies | Kaumil Gajrawala | $152 | $109.14 | +72.7% | Nov 4, 2025 |
| UBS | Analyst unavailable | $128 | $118.82 | +45.5% | Oct 8, 2025 |
| Barclays | Analyst unavailable | $112 | $122.67 | +27.3% | Oct 1, 2025 |
| Barclays | Lauren Lieberman | $119 | $126.78 | +35.2% | Jul 15, 2025 |
| Barclays | Lauren Lieberman | $129 | $135.05 | +46.6% | May 7, 2025 |
| Evercore ISI | Javier Escalante | $140 | $135.05 | +59.1% | May 6, 2025 |
| Morgan Stanley | Dara Mohsenian | $150 | $135.05 | +70.5% | May 6, 2025 |
| Wells Fargo | Chris Carey | $142 | $133.64 | +61.4% | May 6, 2025 |
| Barclays | Lauren Lieberman | $139 | $145.63 | +58.0% | Mar 27, 2025 |
| Goldman Sachs | Bonnie Herzog | $132 | $159.56 | +50.0% | Oct 8, 2024 |
| Jefferies | Kaumil Gajrawala | $187 | $165.83 | +112.5% | Oct 1, 2024 |
| Barclays | Lauren Lieberman | $122 | $136.31 | +38.6% | Jul 19, 2024 |
| Wells Fargo | Chris Carey | $135 | $139.63 | +53.4% | May 2, 2024 |
| Jefferies | Kaumil Gajrawala | $145 | $150.52 | +64.8% | Mar 26, 2024 |
| RBC Capital | Nik Modi | $138 | $145.97 | +56.8% | Jan 30, 2024 |
| Raymond James | Olivia Tong | $185 | $124.69 | +110.2% | Oct 5, 2023 |
| J.P. Morgan | Ken Goldman | $153 | $155.1 | +73.9% | Sep 8, 2023 |
| Morgan Stanley | Analyst unavailable | $145 | $141 | +64.8% | Feb 3, 2023 |
| Raymond James | Analyst unavailable | $165 | $141 | +87.5% | Feb 3, 2023 |
| Jefferies | Analyst unavailable | $145 | $143.32 | +64.8% | Feb 1, 2023 |
| Wells Fargo | Analyst unavailable | $135 | $140.39 | +53.4% | Jan 3, 2023 |
| Deutsche Bank | Analyst unavailable | $151 | $146.7 | +71.6% | Dec 6, 2022 |
| Barclays | Analyst unavailable | $101 | $148.71 | +14.8% | Aug 19, 2022 |
| Raymond James | Olivia Tong | $160 | $143.89 | +81.8% | Jul 12, 2022 |
| D.A. Davidson | Analyst unavailable | $123 | $147.56 | +39.8% | May 3, 2022 |
| Morgan Stanley | Analyst unavailable | $137 | $143.28 | +55.7% | May 3, 2022 |
| Wells Fargo | Analyst unavailable | $130 | $143.28 | +47.7% | May 3, 2022 |
| Barclays | Lauren Lieberman | $117 | $148.34 | +33.0% | Apr 29, 2022 |
| Deutsche Bank | Steve Powers | $146 | $150.65 | +65.9% | Apr 24, 2022 |
| D.A. Davidson | Linda Bolton Weiser | $127 | $143.22 | +44.3% | Feb 8, 2022 |
| UBS | Peter Grom | $148 | $141.41 | +68.2% | Feb 4, 2022 |
| Bernstein | Callum Elliott | $155 | $166.99 | +76.1% | Feb 2, 2022 |
| Credit Suisse | Kaumil Gajrawala | $160 | $164.72 | +81.8% | Jan 26, 2022 |
| Jefferies | Kevin Grundy | $185 | $176.27 | +110.2% | Jan 5, 2022 |
Track every rating change on CLX the moment it posts. Free to start.
Start freeGet the CLX recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.